This application is directed to catheter pumps for mechanical circulatory support of a heart.
Heart disease is a major health problem that has high mortality rate. Physicians increasingly use mechanical circulatory support systems for treating heart failure. The treatment of acute heart failure requires a device that can provide support to the patient quickly. Physicians desire treatment options that can be deployed quickly and minimally-invasively.
Mechanical circulatory support (MCS) systems and ventricular assist devices (VADs) have gained greater acceptance for the treatment of acute heart failure, such as to stabilize a patient after cardiogenic shock, during treatment of acute myocardial infarction (MI) or decompensated heart failure, or to support a patient during high risk percutaneous coronary intervention (PCI). An example of an MCS system is a rotary blood pump placed percutaneously, e.g., via a catheter without a surgical cutdown.
In a conventional approach, a blood pump is inserted into the body and connected to the cardiovascular system, for example, to the left ventricle and the ascending aorta to assist the pumping function of the heart. Other known applications include pumping venous blood from the right ventricle to the pulmonary artery for support of the right side of the heart. Typically, acute circulatory support devices are used to reduce the load on the heart muscle for a period of time, to stabilize the patient prior to heart transplant or for continuing support.
There is a need for improved mechanical circulatory support devices for treating acute heart failure. There is a need for devices designed to provide near full heart flow rate and inserted percutaneously (e.g., through the femoral artery without a cutdown).
There is a need for a pump with improved performance and clinical outcomes. There is a need for a pump that can provide elevated flow rates with reduced risk of hemolysis and thrombosis. There is a need for a pump that can be inserted minimally-invasively and provide sufficient flow rates for various indications while reducing the risk of major adverse events.
In one aspect, there is a need for a heart pump that can be placed minimally-invasively, for example, through a 15FR or 12FR incision. In one aspect, there is a need for a heart pump that can provide an average flow rate of 4 Lpm or more during operation, for example, at 62 mmHg of head pressure.
While the flow rate of a rotary pump can be increased by rotating the impeller faster, higher rotational speeds are known to increase the risk of hemolysis, which can lead to adverse outcomes and in some cases death. Higher speeds also lead to performance and patient comfort challenges. Many percutaneous ventricular assist devices (VADs) have driveshafts between the motor and impeller rotating at high speeds. Some percutaneous VADs are designed to rotate at speeds of more than 15,000 RPM, and in some case more than 25,000 RPM in operation. The vibration, noise, and heat from the motor and driveshaft can cause discomfort to the patient when positioned, especially when positioned inside the body. Accordingly, there is a need to for a device that improves performance and patient comfort with a high speed motor.
There is a need for a motor configured to drive an operative device, e.g., a impeller, at a distal portion of the pump. It can be important for the motor to be configured to allow for percutaneous insertion of the pump's impeller.
These and other problems are overcome by the inventions described herein.
There is an urgent need for a pumping device that can be inserted percutaneously and also provide full cardiac rate flows of the left, right, or both the left and right sides of the heart when called for.
In one embodiment, a catheter pump system is disclosed. The catheter pump system can include an impeller and a catheter body having a lumen therethrough. The catheter pump system can include a drive shaft disposed inside the catheter body and coupled with the impeller at a distal portion of the drive shaft. The catheter pump system can include a motor assembly comprising a rotor mechanically coupled with a proximal portion of the drive shaft. The catheter pump system can include a heat exchanger coupled with the motor assembly to remove heat therefrom, the heat exchanger comprising a volume to receive fluid.
In another embodiment, a catheter pump system is disclosed. The catheter pump system can include an impeller and a catheter body having a lumen therethrough. The catheter pump system can include a drive shaft disposed inside the catheter body and coupled with the impeller at a distal portion of the drive shaft, the drive shaft configured such that rotation of the drive shaft causes the impeller to rotate. The catheter pump system can include a motor assembly. The motor assembly can include a motor housing and a chamber disposed in the motor housing, at least a portion of the chamber in fluid communication with the lumen of the catheter body. The motor assembly can include a damper configured to reduce the transmission of vibrations from the motor assembly.
In yet another embodiment, a catheter pump system is disclosed. The catheter pump system can include an impeller and a catheter body having a lumen therethrough, the impeller mechanically coupled with a distal portion of the catheter body. The catheter pump system can include a guidewire guide tube disposed through the lumen from a proximal portion of the catheter pump to a distal portion of the catheter pump, the guidewire guide tube configured to receive a guidewire therein. The catheter pump system can include an end cap secured to a proximal end portion of the guide tube, the end cap configured such that axial movement of the end cap relative to the catheter body causes the guidewire guide tube to be removed from the catheter pump. The catheter pump system can include a resealable closure device disposed at a proximal portion of the catheter pump, the closure device configured such that when the guidewire guide tube is removed from the catheter pump, the closure device encloses the proximal portion of the catheter pump.
In another embodiment, a catheter pump system is disclosed. The catheter pump system can include an impeller and a catheter body having a lumen therethrough. The catheter pump system can include a drive shaft disposed inside the catheter body and coupled with the impeller at a distal portion of the drive shaft. The catheter pump system can include a motor assembly. The motor assembly can comprise a housing and a stator assembly within the housing. The motor assembly can comprise a rotor positioned within the stator assembly, the rotor commutated by the stator, the rotor connected to a proximal portion of the drive shaft. The motor assembly can comprise a thermal layer disposed within the housing and configured to transfer heat away from the stator and/or the rotor.
A more complete appreciation of the subject matter of this application and the various advantages thereof can be realized by reference to the following detailed description, in which reference is made to the accompanying drawings in which:
More detailed descriptions of various embodiments of components for heart pumps useful to treat patients experiencing cardiac stress, including acute heart failure, are set forth below.
This application is generally directed to apparatuses for inducing motion of a fluid relative to the apparatus. Exemplars of circulatory support systems for treating heart failure, and in particular emergent and/or acute heart failure, are disclosed in U.S. Pat. Nos. 4,625,712; 4,686,982; 4,747,406; 4,895,557; 4,944,722; 6,176,848; 6,926,662; 7,022,100; 7,393,181; 7,841,976; 8,157,719; 8,489,190; 8,597,170; 8,721,517 and U.S. Pub. Nos. 2012/0178986 and 2014/0010686, the entire contents of which patents and publications are incorporated by reference for all purposes. In addition, this application incorporates by reference in its entirety and for all purposes the subject matter disclosed in each of the following concurrently filed applications and the provisional applications to which they claim priority: application Ser. No. 15/635,531, entitled “REDUCED ROTATIONAL MASS MOTOR ASSEMBLY FOR CATHETER PUMP,” filed on Jun. 28, 2017 and claiming priority to U.S. Provisional Patent Application No. 62/106,670; and application Ser. No. 15/003,696, now U.S. Pat. No. 9,675,738, entitled “ATTACHMENT MECHANISMS FOR MOTOR OF CATHETER PUMP,” filed on Jan. 21, 2016 and claiming priority to U.S. Provisional Patent Application No. 62/106,673.
In one example, an impeller can be coupled at a distal portion of the apparatus. Some embodiments generally relate to various configurations for a motor assembly adapted to drive an impeller at a distal end of a catheter pump, e.g., a percutaneous heart pump. In such applications, the disclosed motor assembly is disposed outside the patient in some embodiments. In other embodiments, the disclosed motor assembly and/or features of the motor are miniaturized and sized to be inserted within the body, e.g., within the vasculature.
The pump 100A includes a catheter assembly that can be coupled with the motor assembly 1 and can house an impeller in an impeller assembly 116A within a distal portion of the catheter assembly of the pump 100A. In various embodiments, the impeller is rotated remotely by the motor 1 when the pump 100A is operating. For example, the motor 1 can be disposed outside the patient. In some embodiments, the motor 1 is separate from the console 122, e.g., to be placed closer to the patient. In the exemplary system the pump is placed in the patient in a sterile environment and the console is outside the sterile environment. In one embodiment, the motor is disposed on the sterile side of the system. In other embodiments, the motor 1 is part of the console 122.
In still other embodiments, the motor is miniaturized to be insertable into the patient. For example,
The impeller assembly 116A can be expandable and collapsible. In the collapsed state, the distal end of the catheter pump 100A can be advanced to the heart, for example, through an artery. In the expanded state the impeller assembly 116A is able to pump blood at relatively high flow rates. In particular, the expandable cannula and impeller configuration allows for decoupling of the insertion size and flow rate, in other words, it allows for higher flow rates than would be possible through a lumen limited to the insertion size with all other things being equal. In
The mechanical components rotatably supporting the impeller within the impeller assembly 116A permit relatively high rotational speeds while controlling heat and particle generation that can come with high speeds. The infusion system delivers a cooling and lubricating solution to the distal portion of the catheter pump 100A for these purposes. The space for delivery of this fluid is extremely limited. Some of the space is also used for return of the fluid supplied to the patient as waste fluid. Providing secure connection and reliable routing of the supplied fluid into and out of the catheter pump 100A is critical and challenging in view of the small profile of the catheter assembly.
When activated, the catheter pump 100A can effectively support, restore and/or increase the flow of blood out of the heart and through the patient's vascular system. In various embodiments disclosed herein, the pump 100A can be configured to produce a maximum flow rate (e.g. low mm Hg) of greater than 4 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, greater than 6 Lpm, greater than 6.5 Lpm, greater than 7 Lpm, greater than 7.5 Lpm, greater than 8 Lpm, greater than 9 Lpm, or greater than 10 Lpm. In various embodiments, the pump 100A can be configured to produce an average flow rate at 62 mmHg of greater than 2 Lpm, greater than 2.5 Lpm, greater than 3 Lpm, greater than 3.5 Lpm, greater than 4 Lpm, greater than 4.25 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, or greater than 6 Lpm.
Various aspects of the pump and associated components can be combined with or substituted for those disclosed in U.S. Pat. Nos. 7,393,181; 8,376,707; 7,841,976; 7,022,100; and 7,998,054, and in U.S. Pub. Nos. 2011/0004046; 2012/0178986; 2012/0172655; 2012/0178985; and 2012/0004495, the entire contents of each of which are incorporated herein for all purposes by reference. In addition, this application incorporates by reference in its entirety and for all purposes the subject matter disclosed in each of the following applications: U.S. Patent Publication No. US 2013/0303970, entitled “DISTAL BEARING SUPPORT,” filed on Mar. 13, 2013; U.S. Patent Publication No. US 2014/0275725, entitled “FLUID HANDLING SYSTEM,” filed on Mar. 11, 2014; U.S. Patent Publication No. US 2013/0303969, entitled “SHEATH SYSTEM FOR CATHETER PUMP,” filed on Mar. 13, 2013; U.S. Patent Publication No. US 2013/0303830, entitled “IMPELLER FOR CATHETER PUMP,” filed on Mar. 13, 2013; U.S. Patent Publication No. US 2014/0012065, entitled “CATHETER PUMP,” filed on Mar. 13, 2013; and U.S. Patent Publication No. US 2014/0010686, entitled “MOTOR ASSEMBLY FOR CATHETER PUMP,” filed on Mar. 13, 2013.
Moving from a distal end 1450 of the catheter assembly of the catheter pump 100A of
In
The priming operation can proceed by introducing fluid into the sealed priming apparatus 1400 to expel air from the impeller assembly 116A and the elongate body 174A. Fluid can be introduced into the priming apparatus 1400 in a variety of ways. For example, fluid can be introduced distally through the elongate body 174A into the priming apparatus 1400. In other embodiments, an inlet, such as a luer, can optionally be formed on a side of the primer housing 1401 to allow for introduction of fluid into the priming apparatus 1400. A gas permeable membrane can be disposed on a distal end 1404 of the primer housing 1401. The gas permeable membrane can permit air to escape from the primer housing 1401 during priming.
The priming apparatus 1400 also can advantageously be configured to collapse an expandable portion of the catheter pump 100A. The primer housing 1401 can include a funnel 1415 where the inner diameter of the housing decreases from distal to proximal. The funnel may be gently curved such that relative proximal movement of the impeller housing causes the impeller housing to be collapsed by the funnel 1415. During or after the impeller housing has been fully collapsed, the distal end 170A of the elongate body 174A can be moved distally relative to the collapsed housing. After the impeller housing is fully collapsed and retracted into the elongate body 174A of the sheath assembly, the catheter pump 100A can be removed from the priming housing 1400 before a percutaneous heart procedure is performed, e.g., before the pump 100A is activated to pump blood. The embodiments disclosed herein may be implemented such that the total time for infusing the system is minimized or reduced. For example, in some implementations, the time to fully infuse the system can be about six minutes or less. In other implementations, the time to infuse can be about three minutes or less. In yet other implementations, the total time to infuse the system can be about 45 seconds or less. It should be appreciated that lower times to infuse can be advantageous for use with cardiovascular patients.
With continued reference to
Further, as shown in
In addition, a waste line 7 can extend from the motor assembly 1 to a waste reservoir 126. Waste fluid from the catheter pump 100A can pass through the motor assembly 1 and out to the reservoir 126 by way of the waste line 7. In various embodiments, the waste fluid flows to the motor assembly 1 and the reservoir 126 at a flow rate which is lower than that at which the fluid is supplied to the patient. For example, some of the supplied fluid may flow out of the catheter body 120 and into the patient by way of one or more bearings. The waste fluid (e.g., a portion of the fluid which passes proximally back through the motor from the patient) may flow through the motor assembly 1 at any suitable flow rate, e.g., at a flow rate in a range of 5 mL/hr to 20 mL/hr, or more particularly, in a range of 10 mL/hr to 15 mL/hr.
Access can be provided to a proximal end of the catheter assembly of the catheter pump 100A prior to or during use. In one configuration, the catheter assembly 101 is delivered over a guidewire 235. The guidewire 235 may be conveniently extended through the entire length of the catheter assembly 101 of the catheter pump 100A and out of a proximal end 1455 of the catheter assembly 101. In various embodiments, the connection between the motor assembly 1 and the catheter assembly 101 is configured to be permanent, such that the catheter pump, the motor housing and the motor are disposable components. However, in other implementations, the coupling between the motor housing and the catheter assembly is disengageable, such that the motor and motor housing can be decoupled from the catheter assembly after use. In such embodiments, the catheter assembly distal of the motor can be disposable, and the motor and motor housing can be re-usable.
In addition,
In one approach, the guidewire 235 is first placed through a needle into a peripheral blood vessel, and along the path between that blood vessel and the heart and into a heart chamber, e.g., into the left ventricle. Thereafter, a distal end opening of the catheter pump 100A and guidewire guide tube 20 can be advanced over the proximal end of the guidewire 235 to enable delivery to the catheter pump 100A. After the proximal end of the guidewire 235 is urged proximally within the catheter pump 100A and emerges from the guidewire opening 237 and/or guidewire guide 20, the catheter pump 100A can be advanced into the patient. In one method, the guidewire guide 20 is withdrawn proximally while holding the catheter pump 100A.
Alternatively, the clinician can thus insert the guidewire 235 through the proximal guidewire opening 237 and urge the guidewire 235 along the guidewire guide tube 20. The clinician can continue urging the guidewire 235 through the patient's vascular system until the distal end of the guidewire 235 is positioned in the desired position, e.g., in a chamber of the patient's heart, a major blood vessel or other source of blood. As shown in
After removing at least the guidewire 235, the clinician can activate the motor 1 to rotate the impeller and begin operation of the pump 100A.
One or more flanges 11A, 11B can mechanically couple the flow diverter 3 to an external housing (not shown). The flanges 11A, 11B are examples of mount structures that can be provided, which can include in various embodiments dampers to isolate the motor assembly 1 from external shock or vibration. In some embodiments, mount structures can include dampers configured to isolate an outer housing or the environment external to the motor assembly 1 from shock or vibration generated by the motor assembly 1. In addition, the guidewire guide tube 20 can extend proximally through the motor assembly 1 and can terminate at a tube end cap 8. As explained above, the guidewire 235 can be inserted within the guide tube 20 for guiding the catheter pump 100A to the heart.
The rotor 15 and stator assembly 2 can be configured as or be components of a frameless-style motor for driving the impeller assembly 116A at the distal end of the pump 100A. For example, the stator assembly 2 can comprise a stator and a plurality of conductive windings producing a controlled magnetic field. The rotor 15 can comprise a magnetic material, e.g., can include one or more permanent magnets. In some embodiments, the rotor 15 can comprise a multi-pole magnet, e.g., a four-pole or six-pole magnet. Providing changing electrical currents through the windings of the stator assembly 2 can create magnetic fields that interact with the rotor 15 to cause the rotor 15 to rotate. This is commonly referred to as commutation. The console 122 can provide electrical power (e.g., 24V) to the stator assembly 2 to drive the motor assembly 1. One or more leads can electrically communicate with the stator assembly 2, e.g., with one or more Hall sensors used to detect the speed and/or position of the motor. In other embodiments, other sensors (e.g., optical sensors) can be used to measure motor speed. The rotor 15 can be secured to an output shaft 13 (which can comprise a hollow shaft with a central lumen) such that rotation of the rotor 15 causes the output shaft 13 to rotate. In various embodiments, the motor assembly 1 can comprise a direct current (DC) brushless motor. In other embodiments, other types of motors can be used, such as AC motors, etc. As shown in
In various embodiments, it can be important to provide a heat removal system to limit buildup of heat in the motor assembly 1 during operation. For example, it can be important to maintain external surfaces of the motor assembly 1 at a temperature less than about 40° C. if the motor assembly 1 is positioned near the patient. For example, an external surface of an external housing 40 of the motor assembly 1 may be kept at or below this temperature. In some respects, regulatory guidelines can require that no part in contact with skin exceed 40° C. To that end, various strategies for heat management are employed by the inventions described herein. It should be appreciated that, as used herein, cooling refers to transferring away or dissipating heat, and in certain respects, cooling is used interchangeably with removing heat. Advantageously, some embodiments disclosed herein can utilize a heat removal system comprising one or more thermal layers which direct heat away from the heat-generating component (i.e., motor assembly 1) to reduce the temperature thereof. The one or more thermal layers may utilize waste fluid returning from the patient to remove heat in some embodiments. In other embodiments, the one or more thermal layers may be supplied with a coolant, such as a liquid or gaseous coolant, to cool the components of the motor assembly 1 and dissipate heat. In the embodiment illustrated in
Although the heat exchanger 30 is illustrated as a coiled lumen, e.g., as a helix, in
The output shaft 13 (which is secured to the rotor 15) can be mechanically coupled with the proximal end portion of a drive shaft 16. The drive shaft 16 can extend distally through an internal lumen of the catheter body 120A. A distal end portion of the drive shaft 16 can mechanically connect with the impeller. Thus, rotation of the rotor 15 can cause the output shaft 13 to rotate, which, in turn, can cause the drive shaft 16 and the impeller to rotate. Further, a lumen can extend through the output shaft 13 and the rotor 15. In certain embodiments, the lumen of the rotor 15 is coupled with a lumen of the catheter body 120A such that the guidewire guide tube 20 can extend through the lumen within the rotor 15 and into the lumen of the catheter body 120A. In addition, the drive shaft 16 comprises a braided shaft having an internal lumen. The braided drive shaft 16 or cable can be permeable to liquid that can flow from outside the drive shaft 16 to within the internal lumen of the drive shaft 16 (and vice versa).
Further, as shown in
As explained above, it can be important to ensure that the motor assembly 1 is adequately cooled. Various components of the motor assembly 1 can generate heat. For example, moving parts within the motor assembly 1 (e.g., the rotating output shaft 13 and/or drive shaft 16) can generate heat by virtue of losses through friction, vibrations, and the like, which may increase the overall temperature of the motor assembly 1. Further, heat can be generated by the electrical current flowing through the stator assembly 2 and/or by induction heating caused by conductive components inside a rotating magnetic field. Furthermore, friction between the bearings 18 and the output shaft 13 and/or friction between the drive shaft 16 and the inner wall of catheter body 120A may also generate undesirable heat in the motor assembly. Inadequate cooling can result in temperature increases of the motor assembly 1, which can present patient discomfort, health risks, or performance losses. This can lead to undesirable usage limitations and engineering complexity, for example, by requiring mitigation for differential heat expansion of adjacent components of different materials. Accordingly, various embodiments disclosed herein can advantageously transfer away generated heat and cool the motor assembly 1 such that the operating temperature of the assembly 1 is sufficiently low to avoid such complexities of use or operation and/or other components of the system. For example, various heat transfer components and/or thermal layers can be used to move heat away from thermal generation sources and away from the patient. Various aspects of the illustrated device herein are designed to reduce the risk of hot spots, reduce the risk of heat spikes, and/or improve heat dissipation to the environment and away from the patient.
A first portion 17a of fluid from the catheter pump 100A can flow proximally through an inner lumen 58 of the catheter body 120A. For example, after initially cooling distal components, some or all of the fluid 35 can flow within the drive shaft 16 and/or around the periphery of the drive shaft 16. After initially cooling distal components some or all of the fluid 35 can flow in a space disposed radially between the drive shaft 16 and the catheter body 120A. As shown in
Thermal management of the motor assembly 1 can be improved by directing fluid through the heat exchanger 30. For example, in the embodiment of
In the embodiment of
Unlike the embodiment of
Although the fluid 35 is described as comprising saline in some embodiments, it should be appreciated that other fluids (such as refrigerants, e.g., R134) can be used within the heat exchanger 30. For example, in other embodiments, a first portion 39a of a cooling fluid 39 other than the supply fluid (e.g., other than saline) can be supplied to an inlet of the heat exchanger 30. A second portion 39b of the cooling fluid can pass through the heat exchanger 30 to draw heat away from the motor assembly. A third portion 39c of the cooling fluid can be conveyed through an outlet of the heat exchanger 30 and into the waste reservoir 126. The cooling fluid 39 can comprise any suitable type of fluid, e.g., any suitable cooling liquid or gas. For example, in some embodiments, the cooling fluid 39 can comprise a refrigerant such as R134A can be used. In other embodiments, water or another liquid may be used as the cooling fluid 39. In still other embodiments, the cooling fluid 39 can comprise a gas, such as air, nitrogen, etc. For example, in some embodiments, the cooling fluid 39 can comprise air supplied by pressurized air systems that are frequently available in hospitals and other clinical settings. The use of such conventional pressurized air systems can advantageously reduce the number of external supply reservoirs provided with the catheter pump system, which can reduce costs and simplify packaging. Furthermore, a chiller or other cooling apparatus can be provided upstream of the heat exchanger 30 to cool the supplied fluid 35 and/or cooling fluid 39 prior to the fluid 35 and/or cooling fluid 39 entering the heat exchanger 30. Cooling the fluid 35 and/or cooling fluid 39 can advantageously improve the thermal management of the motor assembly 1. Advantageously, using a cooling fluid 39 which is different from the fluid 35 supplied to the patient may reduce the temperature to a greater degree than using the fluid 35 alone. For example, the cooling fluid 39 may have superior heat transfer qualities relative to the fluid 35.
In the embodiment of
In the embodiment of
Still other thermal management techniques may be suitable in combination with the embodiments disclosed herein. For example, U.S. Patent Publication Nos. 2014/0031606 and 2011/0295345, which are incorporated by reference herein in their entirety and for all purposes, describe structures and materials which may be incorporated in place of or in addition to the devices described above to manage heat effectively, as will be understood by one of skill from the description herein. Furthermore, as explained herein, the heat exchanger 30 can comprise any suitable shape or configuration. For example, the heat exchanger 30 can comprise a jacket (such as an annular cylinder or sleeve) disposed about the stator assembly 2 in some embodiments. In some embodiments, the systems disclosed in
Operation of the motor assembly 1 may also generate undesirable vibrations. For example, high magnitude vibrations can be inconvenient for the patient or clinician, and/or can damage components of the motor assembly 1. One way that vibrations are reduced and controlled in the disclosed embodiments is by providing the journal bearings 18A, 18B (
In various embodiments, dampening elements are used to limit or eliminate transmission of vibration and noise from the rotating portions of the motor assembly 1 to the rest of the motor assembly (e.g. housing 40). In various embodiments, the rotation elements are connected to the stationary elements only through damping elements. A damping element 41A, 41B can be disposed radially within the flanges 11A, 11B. An inner flange portion 44A, 44B can be disposed radially inward of the damping element 41A, 41B. Suitable materials and structures for the damping elements include, but are not limited to, rubber, elastomers, polymers, springs, and the like. In the illustrated embodiments, the damping element 41A, 41B is formed of rubber, a thermoplastic elastomer (e.g., polyurethane), or other damping materials understood by one of skill in the art. In various embodiments, the damping elements comprise an anti-vibration mount formed of a relatively rigid element and a compression element. The inner flange portion 44A, 44B can be secured about the outer surface of the flow diverter 3. In the illustrated embodiments, the inner flange portions 44A, 44B and the flanges 11A, 11B can be stiffer than the damping elements 41A, 41B. For example, in some embodiments, the inner flange portions 44A, 44B and the flanges 11A, 11B can comprise a plastic material and the damping element 41A, 41B can comprise rubber.
Vibrations may be caused by the rotating components of the motor assembly 1, e.g., by rotation of the rotor 15, the output shaft 13, the drive shaft 16, etc. The vibrations can be transmitted outwardly through the inner flange portions 44A, 44B to the damping elements 41A, 41B. The damping elements 41A, 41B can damp the amplitude of the vibrations such that minimal or no vibrations are transmitted through the flanges 11A, 11B to the housing 40. Thus, the use of the flanges 11A, 11B, the damping elements 41A, 41B, and the inner flange portions 44A, 44B can advantageously reduce the transmission of vibrations to the housing 40 and the patient. In various embodiments, the damping elements 41A, 41B can comprise one or more windows therethrough that provide for the routing of fluid and/or electrical lines through the motor assembly 1. Routing fluid and/or electrical lines through these windows can isolate the fluid and/or electrical lines from strain that may be induced by rotating or moving components.
In addition, vibrations can also be caused by rotation of the drive shaft 16, for example, when the drive shaft 16 hits the catheter body 120A. To reduce vibrations caused by rotation of the drive shaft 15, a fitting 43 can be disposed in an opening of the motor housing 40 about the catheter body 120A. The fitting 43 can comprise any suitable fitting that damps vibrations (e.g., rubber). For example, the fitting 43 can comprise a grommet disposed about the catheter body 120A. Vibrations generated by the rotating drive shaft 16 can be transmitted outwardly through the catheter body 120A and can be damped by the fitting 43. The fitting 43 can thereby attenuate and/or eliminate vibrations from being transmitted to the motor housing 40.
A strain relief feature 42 can also be provided on the exterior of the motor housing 40. The strain relief feature 42 can comprise a plurality of holes through which wires can be routed to the motor assembly 1. The strain relief feature 42 can help to route the wires and can prevent the patient or clinician from accidentally pulling on the wires that are connected to the motor assembly 1.
In addition, the embodiments of the motor assembly 1 disclosed herein are advantageously of smaller dimensions and smaller weight as compared with motor assemblies that use two rotating magnets, e.g., a drive magnet and a follower magnet. In one example, a breadboard built according to the description above was found to reduce the overall length of the motor assembly 1 by about 20% and the overall weight by about 40% by comparison to an equivalent assembly with rotor magnet and follower magnet.
In the illustrated embodiments, the output shaft 13 can be permanently coupled with, e.g., laser welded to the drive shaft 16. For example, a welding machine can access the interface 22 by way of the holes 61 formed in the output shaft 13 to weld the output shaft 13 to the drive shaft 16. In other embodiments, the output shaft 13 can be secured to the drive shaft 16 in other ways, e.g., by friction or interference fit, by adhesives, by mechanical fasteners, etc.
Although the embodiments disclosed herein illustrate examples of heat transfer devices (such as the heat exchanger 30), it should be appreciated that other types of heat transfer devices may be suitable. For example, a thermal layer can be disposed within the housing and configured to transfer heat away from the stator and/or the rotor. At least a portion of the thermal layer can be disposed between the rotor and the stator assembly. In some embodiments, the thermal layer and heat transfer system may be employed without requiring external fins which are exposed to the outside environs. In other embodiments, heat fins or other conductive elements can assist in transferring heat away from the stator and/or rotor and to the environment. For example, in some embodiments, internal heat fins or other conductive elements may be disposed within the motor assembly 1 about the stator assembly 2, but may not be exposed to the outside environs. In some embodiments, a fan can be disposed inside the motor housing to assist in dissipating heat. In some embodiments, the motor housing can comprise holes or vents to cause air to flow over the internal heat fins. In some embodiments, at least a portion of the thermal layer is disposed within the rotor, e.g., a lumen disposed within the rotor. In some embodiments, the thermal layer comprises a thermally conductive material. In some embodiments, the thermal layer comprises an inside layer of high thermal conductivity (for absorbing heat spikes) and an outer layer of low thermal conductivity (for dissipating heat into the environment slowly). The thermal layer can also comprise a fluid pipe. In some embodiments, the thermal layer comprises a fluid chamber, the rotor configured to be disposed in fluid in the fluid chamber. In some embodiments, the thermal layer comprises a heat exchanger with a plurality of coils, the coils disposed about a portion of the stator assembly 2 (or other parts of the motor assembly 1). In some embodiments, as explained above, the thermal layer can comprise a heat exchanger comprising a jacket or sleeve (e.g., an annular cylinder) disposed about a portion of the stator assembly 2 and/or other parts of the motor assembly 1.
Although the embodiments disclosed herein have been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present inventions. It is therefore to be understood that numerous modifications can be made to the illustrative embodiments and that other arrangements can be devised without departing from the spirit and scope of the present inventions as defined by the appended claims. Thus, it is intended that the present application cover the modifications and variations of these embodiments and their equivalents.
This application is a Continuation of U.S. patent application Ser. No. 15/588,954, filed on May 8, 2017, now issued U.S. Pat. No. 9,987,404, which is a Continuation of U.S. patent application Ser. No. 15/003,682, filed Jan. 21, 2016, now issued U.S. Pat. No. 9,675,739, which claims priority to U.S. Provisional Patent Application No. 62/106,675, filed on Jan. 22, 2015, the entire contents of which are hereby incorporated by reference herein for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
1902418 | Pilgrim | Mar 1933 | A |
2356659 | De Paiva Aguiar | Aug 1944 | A |
2649052 | Weyer | Aug 1953 | A |
2664050 | Abresch | Dec 1953 | A |
2684035 | Kemp | Jul 1954 | A |
2789511 | Doble | Apr 1957 | A |
2896926 | Chapman | Jul 1959 | A |
2935068 | Donaldson | May 1960 | A |
3080824 | Boyd et al. | Mar 1963 | A |
3455540 | Marcmann | Jul 1969 | A |
3510229 | Smith | May 1970 | A |
3812812 | Hurwitz | May 1974 | A |
3860968 | Shapiro | Jan 1975 | A |
3904901 | Renard et al. | Sep 1975 | A |
3995617 | Watkins et al. | Dec 1976 | A |
4115040 | Knorr | Sep 1978 | A |
4129129 | Amrine | Dec 1978 | A |
4135253 | Reich et al. | Jan 1979 | A |
4143425 | Runge | Mar 1979 | A |
4149535 | Volder | Apr 1979 | A |
4304524 | Coxon | Dec 1981 | A |
4382199 | Isaacson | May 1983 | A |
4392836 | Sugawara | Jul 1983 | A |
4458366 | MacGregor et al. | Jul 1984 | A |
4540402 | Aigner | Sep 1985 | A |
4560375 | Schulte et al. | Dec 1985 | A |
4589822 | Clausen et al. | May 1986 | A |
4625712 | Wampler | Dec 1986 | A |
4655745 | Corbett | Apr 1987 | A |
4686982 | Nash | Aug 1987 | A |
4696667 | Masch | Sep 1987 | A |
4704121 | Moise | Nov 1987 | A |
4728319 | Masch | Mar 1988 | A |
4753221 | Kensey et al. | Jun 1988 | A |
4769006 | Papantonakos | Sep 1988 | A |
4817586 | Wampler | Apr 1989 | A |
4846152 | Wampler et al. | Jul 1989 | A |
4895557 | Moise et al. | Jan 1990 | A |
4900227 | Trouplin | Feb 1990 | A |
4902272 | Milder et al. | Feb 1990 | A |
4906229 | Wampler | Mar 1990 | A |
4908012 | Moise et al. | Mar 1990 | A |
4919647 | Nash | Apr 1990 | A |
4944722 | Carriker et al. | Jul 1990 | A |
4955856 | Phillips | Sep 1990 | A |
4957504 | Chardack | Sep 1990 | A |
4964864 | Summers et al. | Oct 1990 | A |
4969865 | Hwang et al. | Nov 1990 | A |
4976270 | Parl et al. | Dec 1990 | A |
4985014 | Orejola | Jan 1991 | A |
4994017 | Yozu | Feb 1991 | A |
4995857 | Arnold | Feb 1991 | A |
5000177 | Hoffmann et al. | Mar 1991 | A |
5021048 | Buckholtz | Jun 1991 | A |
5045072 | Castillo et al. | Sep 1991 | A |
5049134 | Golding et al. | Sep 1991 | A |
5061256 | Wampler | Oct 1991 | A |
5089016 | Millner et al. | Feb 1992 | A |
5092844 | Schwartz et al. | Mar 1992 | A |
5098256 | Smith | Mar 1992 | A |
5106368 | Uldall et al. | Apr 1992 | A |
5112200 | Isaacson et al. | May 1992 | A |
5112292 | Hwang et al. | May 1992 | A |
5112349 | Summers et al. | May 1992 | A |
5129883 | Black | Jul 1992 | A |
5142155 | Mauze et al. | Aug 1992 | A |
5147186 | Buckholtz | Sep 1992 | A |
5163910 | Schwartz et al. | Nov 1992 | A |
5169378 | Figuera | Dec 1992 | A |
5171212 | Buck et al. | Dec 1992 | A |
5190528 | Fonger et al. | Mar 1993 | A |
5195960 | Hossain et al. | Mar 1993 | A |
5201679 | Velte, Jr. et al. | Apr 1993 | A |
5211546 | Isaacson et al. | May 1993 | A |
5221270 | Parker | Jun 1993 | A |
5234407 | Teirstein et al. | Aug 1993 | A |
5234416 | Macaulay et al. | Aug 1993 | A |
5290227 | Pasque | Mar 1994 | A |
5300112 | Barr | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5344443 | Palma et al. | Sep 1994 | A |
5346458 | Affeld | Sep 1994 | A |
5360317 | Clausen et al. | Nov 1994 | A |
5376114 | Jarvik | Dec 1994 | A |
5393197 | Lemont et al. | Feb 1995 | A |
5393207 | Maher et al. | Feb 1995 | A |
5405341 | Martin | Apr 1995 | A |
5405383 | Barr | Apr 1995 | A |
5415637 | Khosravi | May 1995 | A |
5437541 | Vainrub | Aug 1995 | A |
5449342 | Hirose et al. | Sep 1995 | A |
5458459 | Hubbard et al. | Oct 1995 | A |
5490763 | Abrams et al. | Feb 1996 | A |
5505701 | Anaya Fernandez de Lomana | Apr 1996 | A |
5527159 | Bozeman, Jr. et al. | Jun 1996 | A |
5533957 | Aldea | Jul 1996 | A |
5534287 | Lukic | Jul 1996 | A |
5554114 | Wallace et al. | Sep 1996 | A |
5588812 | Taylor et al. | Dec 1996 | A |
5609574 | Kaplan et al. | Mar 1997 | A |
5613935 | Jarvik | Mar 1997 | A |
5643226 | Cosgrove et al. | Jul 1997 | A |
5678306 | Bozeman, Jr. et al. | Oct 1997 | A |
5692882 | Bozeman, Jr. et al. | Dec 1997 | A |
5702418 | Ravenscroft | Dec 1997 | A |
5704926 | Sutton | Jan 1998 | A |
5707218 | Maher et al. | Jan 1998 | A |
5722930 | Larson, Jr. et al. | Mar 1998 | A |
5725513 | Ju et al. | Mar 1998 | A |
5725570 | Heath | Mar 1998 | A |
5730628 | Hawkins | Mar 1998 | A |
5735897 | Buirge | Apr 1998 | A |
5738649 | Macoviak | Apr 1998 | A |
5741234 | Aboul-Hosn | Apr 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5749855 | Reitan | May 1998 | A |
5755784 | Jarvik | May 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776190 | Jarvik | Jul 1998 | A |
5779721 | Nash | Jul 1998 | A |
5807311 | Palestrant | Sep 1998 | A |
5814011 | Corace | Sep 1998 | A |
5824070 | Jarvik | Oct 1998 | A |
5851174 | Jarvik et al. | Dec 1998 | A |
5859482 | Crowell et al. | Jan 1999 | A |
5868702 | Stevens et al. | Feb 1999 | A |
5868703 | Bertolero et al. | Feb 1999 | A |
5888241 | Jarvik | Mar 1999 | A |
5888242 | Antaki et al. | Mar 1999 | A |
5911685 | Siess et al. | Jun 1999 | A |
5921913 | Siess | Jul 1999 | A |
5941813 | Sievers et al. | Aug 1999 | A |
5951263 | Taylor et al. | Sep 1999 | A |
5957941 | Ream | Sep 1999 | A |
5964694 | Siess et al. | Oct 1999 | A |
6007478 | Siess et al. | Dec 1999 | A |
6007479 | Rottenberg et al. | Dec 1999 | A |
6015272 | Antaki et al. | Jan 2000 | A |
6015434 | Yamane | Jan 2000 | A |
6018208 | Maher et al. | Jan 2000 | A |
6027863 | Donadio, III | Feb 2000 | A |
6053705 | Schoeb et al. | Apr 2000 | A |
6056719 | Mickley | May 2000 | A |
6058593 | Siess | May 2000 | A |
6059760 | Sandmore et al. | May 2000 | A |
6068610 | Ellis et al. | May 2000 | A |
6071093 | Hart | Jun 2000 | A |
6083260 | Aboul-Hosn | Jul 2000 | A |
6086527 | Talpade | Jul 2000 | A |
6086570 | Aboul-Hosn et al. | Jul 2000 | A |
6093001 | Burgreen et al. | Jul 2000 | A |
6106494 | Saravia et al. | Aug 2000 | A |
6113536 | Aboul-Hosn et al. | Sep 2000 | A |
6123659 | Le Blanc et al. | Sep 2000 | A |
6123725 | Aboul-Hosn | Sep 2000 | A |
6132363 | Freed et al. | Oct 2000 | A |
6135943 | Yu et al. | Oct 2000 | A |
6136025 | Barbut et al. | Oct 2000 | A |
6139487 | Siess | Oct 2000 | A |
6152704 | Aboul-Hosn et al. | Nov 2000 | A |
6162194 | Shipp | Dec 2000 | A |
6176822 | Nix et al. | Jan 2001 | B1 |
6176848 | Rau et al. | Jan 2001 | B1 |
6178922 | Denesuk et al. | Jan 2001 | B1 |
6186665 | Maher et al. | Feb 2001 | B1 |
6190304 | Downey et al. | Feb 2001 | B1 |
6190357 | Ferrari et al. | Feb 2001 | B1 |
6200260 | Bolling | Mar 2001 | B1 |
6210133 | Aboul-Hosn et al. | Apr 2001 | B1 |
6210318 | Lederman | Apr 2001 | B1 |
6210397 | Aboul-Hosn et al. | Apr 2001 | B1 |
6214846 | Elliott | Apr 2001 | B1 |
6217541 | Yu | Apr 2001 | B1 |
6227797 | Watterson et al. | May 2001 | B1 |
6228063 | Aboul-Hosn | May 2001 | B1 |
6234960 | Aboul-Hosn et al. | May 2001 | B1 |
6234995 | Peacock, III | May 2001 | B1 |
6245007 | Bedingham et al. | Jun 2001 | B1 |
6245026 | Campbell et al. | Jun 2001 | B1 |
6247892 | Kazatchkov et al. | Jun 2001 | B1 |
6248091 | Voelker | Jun 2001 | B1 |
6254359 | Aber | Jul 2001 | B1 |
6254564 | Wilk et al. | Jul 2001 | B1 |
6287319 | Aboul-Hosn et al. | Sep 2001 | B1 |
6287336 | Globerman et al. | Sep 2001 | B1 |
6295877 | Aboul-Hosn et al. | Oct 2001 | B1 |
6299635 | Frantzen | Oct 2001 | B1 |
6305962 | Maher et al. | Oct 2001 | B1 |
6387037 | Bolling et al. | May 2002 | B1 |
6395026 | Aboul-Hosn et al. | May 2002 | B1 |
6413222 | Pantages et al. | Jul 2002 | B1 |
6422990 | Prem | Jul 2002 | B1 |
6425007 | Messinger | Jul 2002 | B1 |
6428464 | Bolling | Aug 2002 | B1 |
6447441 | Yu et al. | Sep 2002 | B1 |
6454775 | Demarais et al. | Sep 2002 | B1 |
6468298 | Pelton | Oct 2002 | B1 |
6503224 | Forman et al. | Jan 2003 | B1 |
6508777 | Macoviak et al. | Jan 2003 | B1 |
6508787 | Erbel Reimund et al. | Jan 2003 | B2 |
6517315 | Belady | Feb 2003 | B2 |
6517528 | Pantages et al. | Feb 2003 | B1 |
6527699 | Goldowsky | Mar 2003 | B1 |
6532964 | Aboul-Hosn et al. | Mar 2003 | B2 |
6533716 | Schmitz-Rode et al. | Mar 2003 | B1 |
6544216 | Sammler et al. | Apr 2003 | B1 |
6547519 | Deblanc et al. | Apr 2003 | B2 |
6565598 | Lootz | May 2003 | B1 |
6609883 | Woodard et al. | Aug 2003 | B2 |
6610004 | Viole et al. | Aug 2003 | B2 |
6613008 | Aboul-Hosn et al. | Sep 2003 | B2 |
6616323 | McGill | Sep 2003 | B2 |
6623420 | Reich et al. | Sep 2003 | B2 |
6623475 | Siess | Sep 2003 | B1 |
6641093 | Coudrais | Nov 2003 | B2 |
6641558 | Aboul-Hosn et al. | Nov 2003 | B1 |
6645241 | Strecker | Nov 2003 | B1 |
6652548 | Evans et al. | Nov 2003 | B2 |
6660014 | Demarais et al. | Dec 2003 | B2 |
6673105 | Chen | Jan 2004 | B1 |
6692318 | McBride | Feb 2004 | B2 |
6709418 | Aboul-Hosn et al. | Mar 2004 | B1 |
6716189 | Jarvik et al. | Apr 2004 | B1 |
6749598 | Keren et al. | Jun 2004 | B1 |
6776578 | Belady | Aug 2004 | B2 |
6776794 | Hong et al. | Aug 2004 | B1 |
6783328 | Lucke et al. | Aug 2004 | B2 |
6790171 | Gruendeman et al. | Sep 2004 | B1 |
6794784 | Takahashi et al. | Sep 2004 | B2 |
6794789 | Siess et al. | Sep 2004 | B2 |
6814713 | Aboul-Hosn et al. | Nov 2004 | B2 |
6817836 | Nose et al. | Nov 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6860713 | Hoover | Mar 2005 | B2 |
6866625 | Ayre et al. | Mar 2005 | B1 |
6866805 | Hong et al. | Mar 2005 | B2 |
6887215 | McWeeney | May 2005 | B2 |
6889082 | Bolling et al. | May 2005 | B2 |
6901289 | Dahl et al. | May 2005 | B2 |
6926662 | Aboul-Hosn et al. | Aug 2005 | B1 |
6935344 | Aboul-Hosn et al. | Aug 2005 | B1 |
6942611 | Siess | Sep 2005 | B2 |
6949066 | Bearnson et al. | Sep 2005 | B2 |
6966748 | Woodard et al. | Nov 2005 | B2 |
6972956 | Franz et al. | Dec 2005 | B2 |
6974436 | Aboul-Hosn et al. | Dec 2005 | B1 |
6981942 | Khaw et al. | Jan 2006 | B2 |
6984392 | Bechert et al. | Jan 2006 | B2 |
7010954 | Siess et al. | Mar 2006 | B2 |
7011620 | Siess | Mar 2006 | B1 |
7014417 | Salomon | Mar 2006 | B2 |
7022100 | Aboul-Hosn et al. | Apr 2006 | B1 |
7027875 | Siess et al. | Apr 2006 | B2 |
7037069 | Arnold et al. | May 2006 | B2 |
7070555 | Siess | Jul 2006 | B2 |
7122019 | Kesten et al. | Oct 2006 | B1 |
7125376 | Viole et al. | Oct 2006 | B2 |
7144365 | Bolling et al. | Dec 2006 | B2 |
7150711 | Nusser Peter et al. | Dec 2006 | B2 |
7160243 | Medvedev | Jan 2007 | B2 |
7172551 | Leasure | Feb 2007 | B2 |
7175588 | Morello | Feb 2007 | B2 |
7229258 | Wood et al. | Jun 2007 | B2 |
7241257 | Ainsworth et al. | Jul 2007 | B1 |
7262531 | Li et al. | Aug 2007 | B2 |
7264606 | Jarvik et al. | Sep 2007 | B2 |
7267667 | Houde et al. | Sep 2007 | B2 |
7284956 | Nose et al. | Oct 2007 | B2 |
7288111 | Holloway et al. | Oct 2007 | B1 |
7290929 | Smith et al. | Nov 2007 | B2 |
7329236 | Kesten et al. | Feb 2008 | B2 |
7331921 | Viole et al. | Feb 2008 | B2 |
7335192 | Keren et al. | Feb 2008 | B2 |
7341570 | Keren et al. | Mar 2008 | B2 |
7381179 | Aboul-Hosn et al. | Jun 2008 | B2 |
7393181 | McBride et al. | Jul 2008 | B2 |
7469716 | Parrino et al. | Dec 2008 | B2 |
7491163 | Viole et al. | Feb 2009 | B2 |
7534258 | Gomez et al. | May 2009 | B2 |
7605298 | Bechert et al. | Oct 2009 | B2 |
7619560 | Penna et al. | Nov 2009 | B2 |
7633193 | Masoudipour et al. | Dec 2009 | B2 |
7645225 | Medvedev et al. | Jan 2010 | B2 |
7657324 | Westlund et al. | Feb 2010 | B2 |
7682673 | Houston et al. | Mar 2010 | B2 |
7722568 | Lenker et al. | May 2010 | B2 |
7731675 | Aboul-Hosn et al. | Jun 2010 | B2 |
7736296 | Siess et al. | Jun 2010 | B2 |
7758521 | Morris et al. | Jul 2010 | B2 |
7766892 | Keren et al. | Aug 2010 | B2 |
7780628 | Keren et al. | Aug 2010 | B1 |
7785246 | Aboul-Hosn et al. | Aug 2010 | B2 |
7811279 | John | Oct 2010 | B2 |
7819833 | Ainsworth et al. | Oct 2010 | B2 |
7820205 | Takakusagi et al. | Oct 2010 | B2 |
7828710 | Shifflette | Nov 2010 | B2 |
7841976 | McBride et al. | Nov 2010 | B2 |
7878967 | Khanal | Feb 2011 | B1 |
7918828 | Lundgaard et al. | Apr 2011 | B2 |
7927068 | McBride et al. | Apr 2011 | B2 |
7935102 | Breznock et al. | May 2011 | B2 |
7942804 | Khaw | May 2011 | B2 |
7942844 | Moberg et al. | May 2011 | B2 |
7955365 | Doty | Jun 2011 | B2 |
7993259 | Kang et al. | Aug 2011 | B2 |
7998054 | Bolling | Aug 2011 | B2 |
7998190 | Gharib et al. | Aug 2011 | B2 |
8012079 | Delgado, III et al. | Sep 2011 | B2 |
8025647 | Siess et al. | Sep 2011 | B2 |
8079948 | Shifflette | Dec 2011 | B2 |
8110267 | Houston et al. | Feb 2012 | B2 |
8114008 | Hidaka et al. | Feb 2012 | B2 |
8123669 | Siess et al. | Feb 2012 | B2 |
8177703 | Smith et al. | May 2012 | B2 |
8206350 | Mann et al. | Jun 2012 | B2 |
8209015 | Glenn | Jun 2012 | B2 |
8216122 | Kung et al. | Jul 2012 | B2 |
8235943 | Breznock et al. | Aug 2012 | B2 |
8236040 | Mayberry et al. | Aug 2012 | B2 |
8236044 | Robaina | Aug 2012 | B2 |
8255050 | Mohl | Aug 2012 | B2 |
8257312 | Duffy | Sep 2012 | B2 |
8262619 | Chebator et al. | Sep 2012 | B2 |
8277470 | Demarais et al. | Oct 2012 | B2 |
8317715 | Belleville et al. | Nov 2012 | B2 |
8329913 | Murata et al. | Dec 2012 | B2 |
8333687 | Farnan et al. | Dec 2012 | B2 |
8348991 | Weber et al. | Jan 2013 | B2 |
8364278 | Pianca et al. | Jan 2013 | B2 |
8376707 | McBride et al. | Feb 2013 | B2 |
8382818 | Davis et al. | Feb 2013 | B2 |
8388565 | Shifflette | Mar 2013 | B2 |
8409128 | Ferrari | Apr 2013 | B2 |
8414645 | Dwork et al. | Apr 2013 | B2 |
8439859 | Pfeffer et al. | May 2013 | B2 |
8449443 | Rodefeld et al. | May 2013 | B2 |
8485961 | Campbell et al. | Jul 2013 | B2 |
8489190 | Pfeffer et al. | Jul 2013 | B2 |
8535211 | Campbell et al. | Sep 2013 | B2 |
8540615 | Aboul-Hosn et al. | Sep 2013 | B2 |
8545379 | Marseille et al. | Oct 2013 | B2 |
8545380 | Farnan et al. | Oct 2013 | B2 |
8579858 | Reitan et al. | Nov 2013 | B2 |
8585572 | Mehmanesh | Nov 2013 | B2 |
8591393 | Walters et al. | Nov 2013 | B2 |
8597170 | Walters et al. | Dec 2013 | B2 |
8617239 | Reitan | Dec 2013 | B2 |
8684904 | Campbell et al. | Apr 2014 | B2 |
8690749 | Nunez | Apr 2014 | B1 |
8721516 | Scheckel | May 2014 | B2 |
8721517 | Zeng et al. | May 2014 | B2 |
8727959 | Reitan et al. | May 2014 | B2 |
8734331 | Evans et al. | May 2014 | B2 |
8784441 | Rosenbluth et al. | Jul 2014 | B2 |
8790236 | Larose et al. | Jul 2014 | B2 |
8795576 | Tao et al. | Aug 2014 | B2 |
8801590 | Mohl | Aug 2014 | B2 |
8814776 | Hastie et al. | Aug 2014 | B2 |
8814933 | Siess | Aug 2014 | B2 |
8849398 | Evans et al. | Sep 2014 | B2 |
8944748 | Liebing | Feb 2015 | B2 |
8992406 | Corbett | Mar 2015 | B2 |
8998792 | Scheckel | Apr 2015 | B2 |
9028216 | Schumacher et al. | May 2015 | B2 |
9089634 | Schumacher et al. | Jul 2015 | B2 |
9089670 | Scheckel | Jul 2015 | B2 |
9162017 | Evans et al. | Oct 2015 | B2 |
9217442 | Wiessler et al. | Dec 2015 | B2 |
9308302 | Zeng | Apr 2016 | B2 |
9314558 | Er | Apr 2016 | B2 |
9327067 | Zeng et al. | May 2016 | B2 |
9328741 | Liebing | May 2016 | B2 |
9358330 | Schumacher | Jun 2016 | B2 |
9381288 | Schenck et al. | Jul 2016 | B2 |
9421311 | Tanner et al. | Aug 2016 | B2 |
9446179 | Keenan et al. | Sep 2016 | B2 |
20020107506 | McGuckin et al. | Aug 2002 | A1 |
20030018380 | Craig et al. | Jan 2003 | A1 |
20030205233 | Aboul-Hosn et al. | Nov 2003 | A1 |
20030208097 | Aboul-Hosn et al. | Nov 2003 | A1 |
20030231959 | Snider | Dec 2003 | A1 |
20050049696 | Siess et al. | Mar 2005 | A1 |
20050085683 | Bolling et al. | Apr 2005 | A1 |
20050113631 | Bolling et al. | May 2005 | A1 |
20050137680 | Ortiz et al. | Jun 2005 | A1 |
20050165269 | Aboul-Hosn et al. | Jul 2005 | A9 |
20050250975 | Carrier et al. | Nov 2005 | A1 |
20060018943 | Bechert et al. | Jan 2006 | A1 |
20060058869 | Olson et al. | Mar 2006 | A1 |
20060063965 | Aboul-Hosn et al. | Mar 2006 | A1 |
20060089521 | Chang | Apr 2006 | A1 |
20060155158 | Aboul-Hosn | Jul 2006 | A1 |
20060264695 | Viole et al. | Nov 2006 | A1 |
20060270894 | Viole et al. | Nov 2006 | A1 |
20070100314 | Keren et al. | May 2007 | A1 |
20070156006 | Smith et al. | Jul 2007 | A1 |
20080004645 | To et al. | Jan 2008 | A1 |
20080103442 | Kesten et al. | May 2008 | A1 |
20080103516 | Wulfman et al. | May 2008 | A1 |
20080119943 | Armstrong et al. | May 2008 | A1 |
20080132748 | Shifflette | Jun 2008 | A1 |
20080167679 | Papp | Jul 2008 | A1 |
20080275290 | Viole et al. | Nov 2008 | A1 |
20090018567 | Escudero et al. | Jan 2009 | A1 |
20090024085 | To et al. | Jan 2009 | A1 |
20090099638 | Grewe | Apr 2009 | A1 |
20090112312 | LaRose et al. | Apr 2009 | A1 |
20090118567 | Siess | May 2009 | A1 |
20090182188 | Marseille et al. | Jul 2009 | A1 |
20090234378 | Escudero et al. | Sep 2009 | A1 |
20100030186 | Stivland | Feb 2010 | A1 |
20100041939 | Siess | Feb 2010 | A1 |
20100047099 | Miyazaki et al. | Feb 2010 | A1 |
20100127871 | Pontin | May 2010 | A1 |
20100210895 | Aboul-Hosn et al. | Aug 2010 | A1 |
20100268017 | Siess | Oct 2010 | A1 |
20100274330 | Burwell et al. | Oct 2010 | A1 |
20100286791 | Goldsmith | Nov 2010 | A1 |
20110004046 | Campbell et al. | Jan 2011 | A1 |
20110071338 | McBride et al. | Mar 2011 | A1 |
20110076439 | Zeilon | Mar 2011 | A1 |
20110152906 | Escudero et al. | Jun 2011 | A1 |
20110152907 | Escudero et al. | Jun 2011 | A1 |
20110237863 | Ricci et al. | Sep 2011 | A1 |
20110257462 | Rodefeld et al. | Oct 2011 | A1 |
20120004495 | Bolling et al. | Jan 2012 | A1 |
20120029265 | Larose et al. | Feb 2012 | A1 |
20120059213 | Spence et al. | Mar 2012 | A1 |
20120142994 | Toellner | Jun 2012 | A1 |
20120172654 | Bates | Jul 2012 | A1 |
20120172655 | Campbell et al. | Jul 2012 | A1 |
20120178985 | Walters et al. | Jul 2012 | A1 |
20120178986 | Campbell et al. | Jul 2012 | A1 |
20120184803 | Simon et al. | Jul 2012 | A1 |
20120203056 | Corbett | Aug 2012 | A1 |
20120224970 | Schumacher et al. | Sep 2012 | A1 |
20120226097 | Smith et al. | Sep 2012 | A1 |
20120234411 | Scheckel | Sep 2012 | A1 |
20120245404 | Smith et al. | Sep 2012 | A1 |
20120265002 | Roehn et al. | Oct 2012 | A1 |
20130041202 | Toellner et al. | Feb 2013 | A1 |
20130053622 | Corbett | Feb 2013 | A1 |
20130066140 | McBride et al. | Mar 2013 | A1 |
20130085318 | Toellner | Apr 2013 | A1 |
20130096364 | Reichenbach et al. | Apr 2013 | A1 |
20130103063 | Escudero et al. | Apr 2013 | A1 |
20130106212 | Nakazumi et al. | May 2013 | A1 |
20130129503 | McBride et al. | May 2013 | A1 |
20130138205 | Kushwaha et al. | May 2013 | A1 |
20130204362 | Toellner et al. | Aug 2013 | A1 |
20130209292 | Baykut et al. | Aug 2013 | A1 |
20130237744 | Pfeffer et al. | Sep 2013 | A1 |
20130245360 | Schumacher | Sep 2013 | A1 |
20130303969 | Keenan et al. | Nov 2013 | A1 |
20130303970 | Keenan et al. | Nov 2013 | A1 |
20130331639 | Campbell et al. | Dec 2013 | A1 |
20130345492 | Pfeffer et al. | Dec 2013 | A1 |
20140005467 | Farnan et al. | Jan 2014 | A1 |
20140010686 | Tanner et al. | Jan 2014 | A1 |
20140012065 | Fitzgerald et al. | Jan 2014 | A1 |
20140039465 | Schulz Heike et al. | Feb 2014 | A1 |
20140067057 | Callaway et al. | Mar 2014 | A1 |
20140088455 | Christensen et al. | Mar 2014 | A1 |
20140148638 | Larose et al. | May 2014 | A1 |
20140163664 | Goldsmith | Jun 2014 | A1 |
20140255176 | Bredenbreuker et al. | Sep 2014 | A1 |
20140275725 | Schenck et al. | Sep 2014 | A1 |
20140275726 | Zeng | Sep 2014 | A1 |
20140301822 | Scheckel | Oct 2014 | A1 |
20140303596 | Schumacher et al. | Oct 2014 | A1 |
20150025558 | Wulfman et al. | Jan 2015 | A1 |
20150031936 | Larose et al. | Jan 2015 | A1 |
20150051435 | Siess et al. | Feb 2015 | A1 |
20150051436 | Spanier et al. | Feb 2015 | A1 |
20150080743 | Siess et al. | Mar 2015 | A1 |
20150087890 | Spanier et al. | Mar 2015 | A1 |
20150141738 | Toellner et al. | May 2015 | A1 |
20150141739 | Hsu et al. | May 2015 | A1 |
20150151032 | Voskoboynikov et al. | Jun 2015 | A1 |
20150209498 | Franano et al. | Jul 2015 | A1 |
20150250935 | Anderson et al. | Sep 2015 | A1 |
20150290372 | Muller et al. | Oct 2015 | A1 |
20150343179 | Schumacher et al. | Dec 2015 | A1 |
20160184500 | Zeng | Jun 2016 | A1 |
20160250399 | Tiller et al. | Sep 2016 | A1 |
20160250400 | Schumacher | Sep 2016 | A1 |
20160256620 | Scheckel et al. | Sep 2016 | A1 |
Number | Date | Country |
---|---|---|
2701810 | Apr 2009 | CA |
533432 | Mar 1993 | EP |
1207934 | May 2002 | EP |
1393762 | Mar 2004 | EP |
1591079 | Nov 2005 | EP |
2263732 | Dec 2010 | EP |
2298374 | Mar 2011 | EP |
2267800 | Nov 1975 | FR |
2239675 | Jul 1991 | GB |
S48-23295 | Mar 1973 | JP |
H06114101 | Apr 1994 | JP |
H10099447 | Apr 1998 | JP |
500877 | Sep 2002 | TW |
8905164 | Jun 1989 | WO |
9526695 | Oct 1995 | WO |
9715228 | May 1997 | WO |
9737697 | Oct 1997 | WO |
12148 | Mar 2000 | WO |
19097 | Apr 2000 | WO |
43062 | Jul 2000 | WO |
61207 | Oct 2000 | WO |
69489 | Nov 2000 | WO |
117581 | Mar 2001 | WO |
0119444 | Mar 2001 | WO |
124867 | Apr 2001 | WO |
2070039 | Sep 2002 | WO |
3103745 | Dec 2003 | WO |
2005089674 | Sep 2005 | WO |
2005123158 | Dec 2005 | WO |
2009073037 | Jun 2009 | WO |
2009076460 | Jun 2009 | WO |
2011076439 | Jun 2010 | WO |
2010127871 | Nov 2010 | WO |
2010133567 | Nov 2010 | WO |
2010149393 | Dec 2010 | WO |
2011035926 | Mar 2011 | WO |
2011035929 | Mar 2011 | WO |
2011039091 | Apr 2011 | WO |
2011089022 | Jul 2011 | WO |
2012007140 | Jan 2012 | WO |
2012007141 | Jan 2012 | WO |
2013148697 | Oct 2013 | WO |
2013160407 | Oct 2013 | WO |
2014019274 | Feb 2014 | WO |
2015063277 | Jul 2015 | WO |
Entry |
---|
Federal and Drug Administration 510(k) Summary for Predicate Device IMPELLA 2.5 (K112892), prepared on Sep. 5, 2012, 6 pp. |
Extended European Search Report received in European Patent Application No. 14 779928.2, dated Oct. 7, 2016, in 6 pages. (THOR.084EP). |
Extended European Search Report received in European Patent Application No. 14 764392.8, dated Oct. 27, 2016, in 7 pages. (THOR.097EP). |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014379, dated Jul. 25, 2016, in 19 pages (THOR.128WO). |
Schmitz-Rode et al., “Axial flow catheter pump for circulatory support,” Biomedizinische Technik, 2002, Band 4 7, Erganzungsband 1, Tei I 1, pp. 142-143. |
Abiomed, “Impella 5.0 with the Impella Console, Circulatory Support System, Instructions for Use & Clinical Reference Manual,” Jun. 2010, in 122 pages. |
ABIOMED—Recovering Hearts. Saving Lives., Impella 2.5 System, Instructions for Use, Jul. 2007, in 86 sheets. |
Aboul-Hosn et al., “The Hemopump: Clinical Results and Future Applications”, Assisted Circulation 4, 1995, in 14 pages. |
Barras et al., “Nitinol—Its Use in Vascular Surgery arid Other Applications,” Eur. J. Vase. Endovasc. Surg., 2000, pp. 564-569; vol. 19. |
Biscarini et al., “Enhanced Nitinol Properties for Biomedical Applications,” Recent Patents on Biomedical Engineering, 2008, pp. 180-196, vol. 1 (3). |
Cardiovascular Diseases (CVDs) Fact Sheet No. 317; World Health Organization [Online], Sep. 2011. http://www.who.int/mediacentre/factsheets/fs317/en/index.html, accessed on Aug. 29, 2012. |
Compendium of Technical and Scientific Information for the HEMOPUMP Temporary Cardiac Assist System, Johnson & Johnson Interventional Systems, 1988, in 15 pages. |
Dekker et al., “Efficacy of a New Intraaortic Propeller Pump vs the Intraaortic Balloon Pump*, An Animal Study”, Chest, Jun. 2003, vol. 123, No. 6, pp. 2089-2095. |
Duerig et al., “An Overview of Nitinol Medical Applications,” Materials Science Engineering, 1999, pp. 149-160; vol. A273. |
European Search Report received in European Patent Application No. 05799883.3, dated May 10, 2011, in 4 pages. |
Extended European Search Report received in European Patent Application No. 07753903.9, dated Oct. 8, 2012, in 7 pages (THOR.034VEP). |
Grech, “Percutaneous Coronary Intervention, I: History and Development,” BMJ., May 17, 2003, pp. 1080-1082; vol. 326. |
Hsu et al., “Review of Recent Patents on Foldable Ventricular Assist Devices,” Recent Patents on Biomedical Engineering, 2012, pp. 208-222, vol. 5. |
Ide et al., “Evaluation of the Pulsatility of a New Pulsatile Left Ventricular Assist Device—the integrated Cardioassist Catheter-in Dogs,” J. of Thorac and Cardiovasc Sur, Feb. 1994, pp. 569-0575, vol. 107(2). |
Ide et al., “Hemodynamic Evaluation of a New Left Ventricular Assist Device: An Integrated Cardioassist Catheter as a Pulsatile Left Ventricle-Femoral Artery Bypass,” Blackwell Scientific Publications, Inc., 1992, pp. 286-290, vol. 16(3). |
Impella CP®—Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc.; Jul. 2014, 148 pages, www.abiomed.com. |
Impella LD® with the Impella® Controller—Circulatory Support System—Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc., Sep. 2010, 132 pages, www.abiomed.com. |
International Preliminary Examination Report received in International Patent Application No. PCT/US2003/04853, dated Jul. 26, 2004, in 5 pages. |
International Preliminary Examination Report received in International Patent Application No. PCT/US2003/04401, dated May 18, 2004, in 4 pages. |
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in International Patent Application No. PCT/US2005/033416, dated Mar. 20, 2007, in 7 pages. |
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in International Patent Application No. PCT/US2007/007313, dated Sep. 23, 2008, in 6 pages. |
International Preliminary Report on Patentability and Written Opinion received in International Patent Application No. PCT/US2014/020878, dated Sep. 15, 2015, in 8 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2005/033416, dated Dec. 11, 2006, in 8 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2007/007313, dated Mar. 4, 2008, in 6 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020382, dated Jul. 31, 2012, in 11 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020369, dated Jul. 30, 2012, in 10 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020553, dated Aug. 17, 2012, in 8 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2012/020383, dated Aug. 17, 2012; in 9 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040798, dated Aug. 21, 2013, in 16 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040799, dated Aug. 21, 2013, in 19 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040809, dated Sep. 2, 2013, in 25 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048332, dated Oct. 16, 2013, in 17 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048343, dated Oct. 11, 2013, in 15 pages. |
International Search Report and Written Opinion received in International Patent Application No, PCT/US2014/020878, dated May 7, 2014, in 13 pages. |
International Search Reort and Written Opinion received in International Patent Application No. PCT/US2015/026013, dated Jul. 8, 2015, in 12 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026014, dated Jul. 15, 2015, in 13 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026025, dated Jul. 20, 2015, in 12 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/025959, dated Aug. 28, 2015, in 16 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/025960, dated Sep. 3, 2015, in 15 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/045370, dated Nov. 18, 2015, in 12 pages. |
International Search Report received in International Patent Application No. PCT/US2003/004401, dated Nov. 10, 2003, in 9 pages. |
International Search Report received in International Patent Application No. PCT/US2003/004353, dated Jul. 3, 2003, in 3 pages. |
International Search Report Written Opinion received in International Patent Application No. PCT/US2010/040847, dated Dec. 14, 2010, in 17 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2014/020790, dated Aug. 6, 2014, in 12 pages. |
JOMED Reitan Catheter Pump RCP, Percutaneous Circulatory Support, in 10 pages, believed to be published prior to Oct. 15, 2003. |
JOMED Reitan Catheter Pump RCP, Feb. 18, 2003, in 4 pages. |
Krishnamani et al., “Emerging Ventricular Assist Devices for Long-Term Cardiac Support,” National Review, Cardiology, Feb. 2010, pp. 71-76, vol. 7. |
Kunst et al., “Integrated unit for programmable control of the 21 F Hemopump and registration of physiological signals,” Medical & Biological Engineering & Computing, Nov. 1994, pp. 694-696. |
Mihaylov et al., “Development of a New Introduction Technique for the Pulsatile Catheter Pump,” Artificial Organs, 1997, pp. 425-427; vol. 21 (5). |
Mihaylovet al., “Evaluation of the Optimal Driving Mode During Left Ventricular Assist with Pulsatile Catheter Pump in Calves,” Artificial Organs, 1999, pp. 1117-1122; vol. 23(12). |
Minimally Invasive Cardiac Assist JOMED Catheter PumpTM, in 6 pages, believed to be published prior to Jun. 16, 1999. |
Morgan, “Medical Shape Memory Alloy Applications—The Market and its Products,” Materials Science and Engineering, 2004, pp. 16-23, vol. A 378. |
Morsink et al., “Numerical Modelling of Blood Flow Behaviour in the Valved Catheter of the PUCA-Pump, a LVAD,” The International Journal of Artificial Organs, 1997, pp. 277-284; vol. 20(5). |
Nishimura et al, “The Enabler Cannula Pump: A Novel Circulatory Support System,” The International Journal of Artificial Organs, 1999, pp. 317-323; vol. 22(5). |
Petrini et al., “Biomedical Applications of Shape Memory Alloys,” Journal of Metallurgy, 2011, pp. 1-15. |
Raess et al., “Impella 2.5,” J. Cardiovasc. Transl. Res., 2009, pp. 168-172, vol. 2(2). |
Rakhorst et al., “In Vitro Evaluation of the Influence of Pulsatile Intraventricular Pumping on Ventricular Pressure Patterns,” Artificial Organs, 1994, pp. 494-499, vol. 18(7). |
Reitan, Evaluation of a New Percutaneous Cardiac Assist Device, Department of Cardiology, Faculty of Medicine, Lund University, Sweden, 2002, in 172 pages. |
Reitan et al., “Hemodynamic Effects of a New Percutaneous Circulatory Support Device in a Left Ventricular Failure Model,” ASAIO Journal, 2003, pp. 731-736, vol. 49. |
Reitan et al., “Hydrodynamic Properties of a New Percutaneous Intra-Aortic Axial Flow Pump,” ASAIO Journal2000, pp. 323-328. |
Rothman, “The Reitan Catheter Pump: A New Versatile Approach for Hemodynamic Support”, London Chest Hospital Barts & The London NHS Trust, Oct. 22-27, 2006 (TCT 2006: Transcatheter Cardiovascular Therapeutics 18th Annual Scientific Symposium, Final Program), in 48 pages. |
Schmitz-Rode et al., “An Expandable Percutaneous Catheter Pump for Left Ventricular Support,” Journal of the American College of Cardiology, 2005, pp. 1856-1861, vol. 45(11). |
Shabari et al., “Improved Hemodynamics with a Novel Miniaturized Intra-Aortic Axial Flow Pump in a Porcine Model of Acute Left Ventricular Dysfunction,” ASAIO Journal, 2013, pp. 240-245; vol. 59. |
Sharony et al, “Cardiopulmonary Support and Physiology—The Intra-Aortic Cannula Pump: A Novel Assist Device for the Acutely Failing Heart,” The Journal of Thoracic and Cardiovascular Surgery, Nov. 1992, pp. 924-929, vol. 118(5). |
Sharony et al., “Right Heart Support During Off-Pump Coronary Artery Surgery—A Multi-Center Study,” The Heart Surgery Forum, 2002, pp. 13-16, vol. 5(1). |
Siess et al., “Hydraulic refinement of an intraarterial microaxial blood pump”, The International Journal of Artificial Organs, 1995, vol. 18, No. 5, pp. 273-285. |
Siess, “Systemanalyse und Entwicklung intravasaler Rotationspumpen zur Herzunterstlitzung”, Helmholtz-Institut fur Blomedixinische Technik an der RWfH Aachen, Jun. 24, 1998, in 105 pages. |
Siess et al., “Basic design criteria for rotary blood pumps,” H. Masuda, Rotary Blood Pumps, Springer, Japan,2000, pp. 69-83. |
Siess et al., “Concept, realization, and first in vitro testing of an intraarterial microaxial blood pump,” Artificial Organs, 1995, pp. 644-652, vol. 19, No. 7, Blackwell Science, Inc., Boston, International Society for Artificial Organs. |
Siess et al., “From a lab type to a product: A retrospective view on Impella's assist technology,” Artificial Organs, 2001, pp. 414-421, vol. 25, No. 5, Blackwell Science, Inc., International Society for Artificial Organs. |
Siess et al., “System analysis and development of intravascular rotation pumps for cardiac assist,” Dissertation, Shaker Verlag, Aachen, 1999, 39 pages. |
Smith et al., “First-In-Man Study of the Reitan Catheter Pump for Circulatory Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention,” Catheterization and Cardiovascular Interventions, 2009, pp. 859-865, vol. 73(7). |
Sokolowski et al., “Medical Applications of Shape Memory Polymers,” Biomed. Mater. 2007, pp. S23-S27, vol. 2. |
“Statistical Analysis and Clinical Experience with the Recover® Pump Systems”, Impella CardioSystems GmbH, Sep. 2005, 2 sheets. |
Stoeckel et al., “Self-Expanding Nitinol Stents—Material and Design Considerations,” European Radiology, 2003, in 13 sheets. |
Stolinski et al., “The heart-pump interaction: effects of a microaxial blood pump,” International Journal of Artificial Organs, 2002, pp. 1082-1088, vol. 25, Issue 11. |
Supplemental European Search Report received from the European Patent Office in EP Application No. EP 05799883 dated Mar. 19, 2010, 3 pages. |
Takagaki et al., “A Novel Miniature Ventricular Assist Device for Hemodynamic Support,” ASAIO Journal, 2001, pp. 412-416; vol. 47. |
Throckmorton et al., “Flexible Impeller Blades in an Axial Flow Pump for Intravascular Cavopulmonary Assistance of the Fontan Physiology,” Cardiovascular Engineering and Technology, Dec. 2010, pp. 244-255, vol. 1 (4). |
Verkerke et al., “Numerical Simulation of the PUCA Pump, A Left Ventricular Assist Device,” Abstracts of the XIXth ESAO Congress, The International Journal of Artificial Organs, 1992, p. 543, vol. 15(9). |
Verkerke et al., “Numerical Simulation of the Pulsating Catheter Pump: A Left Ventricular Assist Device,” Artificial Organs, 1999, pp. 924-931, vol. 23(10). |
Verkerke et al., “The PUCA Pump: A Left Ventricular Assist Device,” Artificial Organs, 1993, pp. 365-368, vol. 17(5). |
Wampler et al., “The Sternotomy Hemopump, A Second Generation Intraarterial Ventricular Assist Device,” ASAIO Journal, 1993, pp. M218-M223, vol. 39. |
Weber et al., “Principles of Impella Cardiac Support,” Supplemental to Cardiac Interventions Today, Aug./ Sep. 2009. |
Written Opinion received in International Patent Application No. PCT/US2003/04853, dated Feb. 25, 2004, 5 pages. |
Extended European Search Report received in European Patent Application No. 13813687.4, dated Feb. 24, 2016, in 6 pages. |
Extended European Search Report received in European Patent Application No. 13813867.2, dated Feb. 26, 2016, in 6 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014371, dated May 2, 2016, in 18 pages. |
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014391, dated May 2, 2016, in 17 pages. |
Nullity Action against the owner of the German part DE 50 2007 005 015.6 of European patent EP 2 04 7 872 81, dated Jul. 13, 2015, in 61 pages. |
Throckmorton et al., “Uniquely shaped cardiovascular stents enhance the pressure generation of intravascular blood pumps,” The Journal of Thoracic and Cardiovascular Surgery, Sep. 2012, pp. 704-709, vol. 133, No. 3. |
Extended EP Search Report, dated Dec. 13, 2019, for EP patent application No. EP 19195969.1 (4 pgs.). |
Number | Date | Country | |
---|---|---|---|
20180221551 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
62106675 | Jan 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15588954 | May 2017 | US |
Child | 15946423 | US | |
Parent | 15003682 | Jan 2016 | US |
Child | 15588954 | US |